{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:10:11Z","timestamp":1793387411477,"version":"4.5.0"},"reference-count":23,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,5,19]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral anticoagulation (OAC) effectively reduces stroke risk in patients with atrial fibrillation (AF), but its use after intracranial haemorrhage (ICH) remains controversial due to bleeding concerns. This study aimed to update the evidence on the efficacy and safety of OAC in patients with AF with a history of ICH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis were conducted according to Preferred Reporting Items for Systematic reviews and Meta-Analysis guidelines. We searched PubMed, Scopus and EMBASE for randomised controlled trials (RCTs) comparing OAC versus avoiding anticoagulation in patients with AF post-ICH. The primary outcomes were ischaemic stroke and recurrent ICH. Secondary outcomes included all-cause mortality, cardiovascular mortality, major adverse cardiovascular events (MACE), major haemorrhage and a composite endpoint of \u2018net clinical benefit\u2019 (first incident ischaemic stroke and first incident recurrent ICH). Pooled risk ratios (RRs) with 95% CIs were calculated using a random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four RCTs with 653 participants were included. Anticoagulation was associated with a reduced risk of ischaemic stroke (RR 0.23, 95%\u2009CI 0.06 to 0.91) and increased risk of recurrent ICH (RR 3.60, 95%\u2009CI 1.40 to 9.30). No significant differences were observed in all-cause mortality (RR 0.93, 95%\u2009CI 0.59 to 1.46), cardiovascular death (RR 1.01, 95%\u2009CI 0.32 to 3.18) and for net clinical benefit (RR 0.72, 95%\u2009CI 0.42 to 1.24). Anticoagulation was associated with a significant increased risk of any major haemorrhage (RR 2.49, 95%\u2009CI 1.29 to 4.81) and reduced MACE (RR 0.64, 95%\u2009CI 0.44 to 0.94).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>OAC in patients with AF and prior ICH was associated with a reduced risk of ischaemic stroke and an increased risk of recurrent ICH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42025637606.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2025-336169","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T17:20:22Z","timestamp":1753204822000},"page":"919-927","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Oral anticoagulation versus no anticoagulation for stroke prevention in patients with intracranial haemorrhage and atrial fibrillation: an updated meta-analysis of randomised controlled trials"],"prefix":"10.1136","volume":"96","clinical-trial-number":[{"clinical-trial-number":"nct02801669","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03950076","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4349-3322","authenticated-orcid":false,"given":"Lucio","family":"D\u2019Anna","sequence":"first","affiliation":[{"name":"Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-1175","authenticated-orcid":false,"given":"Francesco","family":"Bax","sequence":"additional","affiliation":[{"name":"Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-8506","authenticated-orcid":false,"given":"Samir","family":"Abu-Rumeileh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Martin Luther University Halle Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-3620","authenticated-orcid":false,"given":"Lorenzo","family":"Barba","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Halle, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Ornello","sequence":"additional","affiliation":[{"name":"University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Valente","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Udine, Udine, Italy"},{"name":"Department of Head Neck and Neuroscience, Azienda sanitaria universitaria Friuli Centrale, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Gigli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Santa Maria della Misericordia University Hospital, Udine, Italy"},{"name":"Department of Neurosciences, University of Udine, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sacco","sequence":"additional","affiliation":[{"name":"Department of Applied Clinical Sciences and Biotechnology, University of L\u2019Aquila, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Merlino","sequence":"additional","affiliation":[{"name":"Department of Head Neck and Neuroscience, Azienda sanitaria universitaria Friuli Centrale, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-7155","authenticated-orcid":false,"given":"Matteo","family":"Foschi","sequence":"additional","affiliation":[{"name":"Neurology Unit, Ospedale S.Maria delle Croci, AUSL Romagna, Ravenna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"2025092709451185000_96.10.919.1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/STROKEAHA.119.028510","article-title":"Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events","volume":"51","author":"Murthy","year":"2020","journal-title":"Stroke"},{"key":"2025092709451185000_96.10.919.2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00415-021-10706-3","article-title":"Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis","volume":"269","author":"Hostettler","year":"2022","journal-title":"J Neurol"},{"key":"2025092709451185000_96.10.919.3","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/STROKEAHA.122.036884","article-title":"Cardiovascular Events After Intracerebral Hemorrhage","volume":"53","author":"Li","year":"2022","journal-title":"Stroke"},{"key":"2025092709451185000_96.10.919.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00075-2"},{"key":"2025092709451185000_96.10.919.5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"The Lancet"},{"key":"2025092709451185000_96.10.919.6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"2025092709451185000_96.10.919.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"2025092709451185000_96.10.919.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310907"},{"key":"2025092709451185000_96.10.919.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638"},{"key":"2025092709451185000_96.10.919.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00315-0"},{"key":"2025092709451185000_96.10.919.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00298-2"},{"key":"2025092709451185000_96.10.919.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00264-7"},{"key":"2025092709451185000_96.10.919.13","unstructured":"Shoamanesh A , Sharma M , Dowlatshahi D . Non-vitamin K oral anticoagulants in intracerebral hemorrhage survivors with atrial fibrillation: primary results of the NASPAF-ICH randomized trial. International Stroke Conference; 2020, Los Angeles, CA: American Heart Association."},{"key":"2025092709451185000_96.10.919.14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","article-title":"Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial","volume":"405","author":"Veltkamp","year":"2025","journal-title":"The Lancet"},{"key":"2025092709451185000_96.10.919.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025092709451185000_96.10.919.16","doi-asserted-by":"crossref","unstructured":"Higgins JPT , Thomas J . Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell, 2019.","DOI":"10.1002\/9781119536604"},{"key":"2025092709451185000_96.10.919.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2025092709451185000_96.10.919.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025092709451185000_96.10.919.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"2025092709451185000_96.10.919.20","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N Engl J Med"},{"key":"2025092709451185000_96.10.919.21","article-title":"Antithrombotic treatment after stroke due to intracerebral haemorrhage","volume":"1","author":"Cochrane","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2025092709451185000_96.10.919.22","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(23)02025-1","article-title":"Anticoagulation in patients with cerebral amyloid angiopathy","volume":"402","author":"Shoamanesh","year":"2023","journal-title":"The Lancet"},{"key":"2025092709451185000_96.10.919.23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jamaneurol.2021.0925","article-title":"Association Between Intracerebral Hemorrhage and Subsequent Arterial Ischemic Events in Participants From 4 Population-Based Cohort Studies","volume":"78","author":"Murthy","year":"2021","journal-title":"JAMA Neurol"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:45:54Z","timestamp":1758991554000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,9,12]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/jnnp-2025-336169"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336169","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]}}}